perflutren: Clinical Trials

10 trials of perflutren, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 active not recruiting, 1 not yet recruiting, 1 recruiting. 10 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 310Completed 6, Active not recruiting 2, Not yet recruiting 1, Recruiting 1
Phase 23Completed 2, Active not recruiting 1

Follow perflutren: new trials by email Literature Review of perflutren trials Research Report on perflutren

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
ultiparametric Magnetic Resonance Imaging, Perflutren lipid microsphere, Transrectal Ultrasound - Prostate Carcinoma
Phase 3Not yet recruitingThomas Jefferson University3002027-01-012026-11-16
Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal
SHAPE measurement (Sonazoid ultrasoud contrast agent), SHAPE measurement (Definity ultrasoud contrast agent) - Liver Diseases, Portal Hypertension
Phase 3RecruitingThomas Jefferson University6602022-11-282026-10-02
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
Perflutren Lipid Microspheres, Ultrasound - Prostate Carcinoma
Phase 3Active not recruitingThomas Jefferson University702022-06-152025-09-04
SHAPE Neoadjuvant Chemotherapy Response
Contrast-Enhanced Ultrasound, Perflutren Lipid Microspheres, Ultrasound - Anatomic Stage III Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma
Phase 2 / Phase 3Active not recruitingKibo Nam1222021-04-192026-09-23
Diagnosing Compartment Syndrome With SHAPE vs Elastography
Definity - Chronic Exertional Compartment Syndrome
Phase 2 / Phase 3CompletedThomas Jefferson University152020-07-012023-12-12
DEF-315 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
DEFINITY® - Cardiac Disease
Phase 3CompletedLantheus Medical Imaging1602018-12-282021-01-28
DEF-314 Better Accuracy in Ejection Fraction (EF) Assessment With DEFINITY
DEFINITY - Cardiac Disease
Phase 3CompletedLantheus Medical Imaging1532018-10-242020-12-17
Contrast-enhanced Ultrasound Evaluation of Chemoembolization
Ultrasound contrast agent (Contrast-enhanced ultrasound), Logiq E9 Scanner (Contrast-enhanced ultrasound) - Hepatocellular Carcinoma, Chemoembolization, Therapeutic
Phase 3CompletedSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University1312016-04-012025-05-06
Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD
Ranibizumab, C3F8 Gas, tPA - Exudative Macular Degeneration, Retinal Hemorrhage
Phase 2 / Phase 3CompletedKing's College Hospital NHS Trust552014-09-012020-07-14
The Silicone Study
Perfluoropropane, Sulfur Hexafluoride, Silicone Oil - Proliferative Vitreoretinopathy, Retinal Detachment
Phase 3CompletedNational Eye Institute (NEI)1985-09-012005-06-24

Conditions studied

Heart Diseases (2)  ·  Prostatic Neoplasms (2)  ·  Carcinoma, Hepatocellular (1)  ·  Chronic Exertional Compartment Syndrome (1)  ·  Hypertension, Portal (1)  ·  Liver Diseases (1)  ·  Macular Degeneration (1)  ·  Retinal Detachment (1)  ·  Retinal Hemorrhage (1)  ·  Vitreoretinopathy, Proliferative (1)  ·  Wet Macular Degeneration (1)

Sponsors

Thomas Jefferson University (4)  ·  Lantheus Medical Imaging (2)  ·  Kibo Nam (1)  ·  King's College Hospital NHS Trust (1)  ·  National Eye Institute (NEI) (1)  ·  Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1)

Countries

United States (8)  ·  Netherlands (1)  ·  Switzerland (1)  ·  United Kingdom (1)

Top investigators

Flemming Forsberg, PhD (3)  ·  John Eisenbrey, PhD (1)  ·  Kibo Nam, MD (1)  ·  Timothy L Jackson, PhD,FRCOpht (1)

Results publications

PMID 32408387, PMID 37847138, PMID 39418015

NIH funding

R01CA252311 (2), R01CA194307 (1), R01DK098526 (1), R37CA234428 (1)